Abstract

Respiratory pharmacology has undergone significant advancements in recent years, offering new insights and therapeutic options for managing respiratory diseases. This review highlights the latest developments in the field, focusing on novel mechanisms of action, innovative drug formulations, and clinical applications. Recent innovations include the evolution of bronchodilators, anti-inflammatory agents, and combination therapies, which have improved the management of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. Advances in drug delivery systems, such as improved inhalation devices and targeted nanoparticlebased therapies, have enhanced the efficacy and safety of treatments. Additionally, the integration of personalized medicine approaches, including biomarker-driven therapies and precision-targeted treatments, is shaping the future of respiratory care. This article provides a comprehensive overview of these advancements, emphasizing their impact on clinical practice and patient outcomes.